Trial Profile
A Double-Blind, Parallel Group, Comparative Study of Intravenous S-021812 in Patients with Influenza Virus Infection
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 May 2016
Price :
$35
*
At a glance
- Drugs Peramivir (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Sponsors Shionogi
- 25 May 2016 New trial record